Provided by Tiger Fintech (Singapore) Pte. Ltd.

Inventrust Properties Corp.

26.89
-0.0300-0.11%
Volume:9.54K
Turnover:255.98K
Market Cap:2.08B
PE:141.53
High:27.07
Open:26.80
Low:26.80
Close:26.92
Loading ...

Adverum Biotechnologies Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
05 Apr

Press Release: InvenTrust Properties Corp. Announces First Quarter 2025 Earnings Release and Conference Call Dates

Dow Jones
·
02 Apr

Adverum Biotechnologies to Participate in the 2025 RBC Capital Markets Ophthalmology Virtual Conference

GlobeNewswire
·
01 Apr

InvenTrust Properties Is Maintained at Overweight by Wells Fargo

Dow Jones
·
26 Mar

InvenTrust Properties Initiated at Peer Perform by Wolfe Research

Dow Jones
·
20 Mar

Wolfe Research Initiates InvenTrust Properties at Peer Perform

MT Newswires Live
·
20 Mar

InvenTrust Properties initiated with a Peer Perform at Wolfe Research

TIPRANKS
·
20 Mar

BRIEF-InvenTrust Properties Corp. Announces 5% Increase In First Quarter 2025 Cash Dividend

Reuters
·
14 Mar

InvenTrust Properties Raises Quarterly Dividend to $0.2376 a Share From $0.2263, Payable April 15 to Holders of Record on March 31

MT Newswires Live
·
14 Mar

Inventrust Properties Corp - Declares 5% Increase in Q1 2025 Cash Dividend

THOMSON REUTERS
·
14 Mar

Inventrust Properties Corp - Annualized Dividend Rate Equal to $0.9505 per Share

THOMSON REUTERS
·
14 Mar

Adverum Biotechnologies Initiates ARTEMIS Phase 3 Study Evaluating Ixo-vec for Wet AMD

GlobeNewswire
·
04 Mar

Adverum Biotechnologies Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
01 Mar

Adverum Biotechnologies to Participate in the Cowen 45th Annual Health Care Conference

GlobeNewswire
·
25 Feb

Inventrust Properties Announces Appointment of Julie M. Swinehart to Board of Directors

THOMSON REUTERS
·
20 Feb

InvenTrust Properties Announces Appointment of Julie M. Swinehart to Board of Directors

Business Wire
·
20 Feb

Stock Track | Inventrust Properties Soars 22.68% Pre-Market as Q4 Earnings Beat Estimates and Dividend Hike Boosts Outlook

Stock Track
·
12 Feb

GenSight Biologics Announces Five-Year Efficacy and Safety Results for LUMEVOQ® Gene Therapy at the Conclusion of the REFLECT Study

Business Wire
·
12 Feb

BRIEF-Inventrust Properties Corp Says Board Approves 5% Dividend Increase Starting April 2025

Reuters
·
12 Feb

InvenTrust Properties Q4 Core FFO Rises; 2025 Outlook Set

MT Newswires Live
·
12 Feb